机构:[1]Department of Urology, Shenzhen People’s Hospital, The Second Clinical College of Jinan University, Shenzhen, Guangdong, P. R. China深圳市康宁医院深圳市人民医院深圳医学信息中心[2]Sun YatsenUniversity Cancer Center State Key Laboratory of Oncology in South China Collaborative Innovation Center of Cancer Medicine, Guangzhou,Guangdong, P. R. China[3]Department of Urology, Sun Yat-sen University Cancer Center, Guangdong, P. R. China[4]Department of Urology, BrazilianNational Institute of Cancer and Hospital Mário Kröeff, Rio de Janeiro, Brazil[5]Section of Urology, National Institute of Cancer, Rio de Janeiro,Brazil[6]Department of Urology, Diakonie Klinikum Stuttgart, Stuttgart, Germany[7]Urological Department, Urological Institute, West China Hospitalof Sichuan University, Chengdu, Sichuan, P. R. China[8]Department of Scientific Research, Norte University, Asunción, Paraguay[9]Department ofPathology, Johns Hopkins University, Baltimore, MD, USA[10]Department of Urology, Johns Hopkins University, Baltimore, MD, USA[11]Departmentof Urology, Affiliated Cancer Hospital of Guangxi Medical University, Nanning, Guangxi, P. R. China[12]Department of Urology, Kaohsiung MedicalUniversity Hospital, Kaohsiung, Taiwan, China[13]Department of Urology, The First People’s Hospital of Chenzhou, Chenzhou, Hunan, P. R. China[14]Department of Urology, Cancer Center of Guangzhou Medical University, Guangzhou, Guangdong, P. R. China[15]Department of Urology, SichuanCancer Hospital, Chengdu, Sichuan, P. R. China[16]Department of Urology Oncological Surgery, Chongqing Cancer Hospital & Institute & Cancer Center,Chongqing, China[17]Department of Urology, Affiliated Tumor Hospital of Xinjiang Medical University, Urumqi, Xinjiang, P. R. China[18]Department ofUrology, Yunnan Provincial Tumor Hospital, The Third Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, P. R. China[19]Departmentof Urology, Dongguan People’s Hospital, Dongguan, Guangdong, P. R. China[20]Department of Pathology, Sun Yat-sen University Cancer Center,Guangzhou, 510060, Guangdong, P. R. China[21]Department of Urology, First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, P.R. China中山大学附属第一医院[22]Department of Pathology, The Chinese University of Hong Kong, Hong Kong, P. R. China[23]Sun Yat-sen University Cancer Center StateKey Laboratory of Oncology in South China Collaborative Innovation Center of Cancer Medicine, Guangzhou, Guangdong, P. R. China[24]Departmentof Urology, Sun Yat-sen University Cancer Center, Guangdong, P. R. China[25]Department of Urology, Brazilian National Institute of Cancer andHospital Mário Kröeff, Rio de Janeiro, Brazil[26]Sun Yat-sen University Cancer Center State Key Laboratory of Oncology in South China CollaborativeInnovation Center of Cancer Medicine, Guangzhou, Guangdong, P. R. China[27]Department of Urology, Sun Yat-sen University Cancer Center, EastGuangzhou, Guangdong, P. R. China[28]Department of Urology, Brazilian National Institute of Cancer and Hospital Mário Kröeff, Rio de Janeiro, Brazil[29]Chefe do Departamento de Oncologia Cinirgica, Beneficencia Portuguesa de Sao Paulo, Sao Paulo, SP, Brasil
第一作者机构:[1]Department of Urology, Shenzhen People’s Hospital, The Second Clinical College of Jinan University, Shenzhen, Guangdong, P. R. China[2]Sun YatsenUniversity Cancer Center State Key Laboratory of Oncology in South China Collaborative Innovation Center of Cancer Medicine, Guangzhou,Guangdong, P. R. China[3]Department of Urology, Sun Yat-sen University Cancer Center, Guangdong, P. R. China[4]Department of Urology, BrazilianNational Institute of Cancer and Hospital Mário Kröeff, Rio de Janeiro, Brazil
通讯作者:
通讯机构:[29]Chefe do Departamento de Oncologia Cinirgica, Beneficencia Portuguesa de Sao Paulo, Sao Paulo, SP, Brasil[*1]Departamento de Oncologia Cirirgica, Beneficencia Portuguesa de Sio Paulo, Sio Paulo, SP, Brasil
推荐引用方式(GB/T 7714):
Li ZS,Ornellas AA,Schwentner C,et al.Editorial comment: A modified clinicopathological tumor staging system for survival prediction of patients with penile cancer(Open Access)[J].International Braz J Urol.2020,46(2):doi:10.1590/S1677-5538.IBJU.2020.02.06.
APA:
Li ZS,Ornellas AA,Schwentner C,Li X,Chaux A...&Gustavo Cardoso Guimaraes.(2020).Editorial comment: A modified clinicopathological tumor staging system for survival prediction of patients with penile cancer(Open Access).International Braz J Urol,46,(2)
MLA:
Li ZS,et al."Editorial comment: A modified clinicopathological tumor staging system for survival prediction of patients with penile cancer(Open Access)".International Braz J Urol 46..2(2020)